P. Kingma

Risk factors for primary sclerosing cholangitis

C. Ponsioen, K. Boonstra, U. Beuers, 2016, Liver international : official journal of the International Association for the Study of the Liver.

α-Glucosidase Inhibition by Miglitol in NIDDM Patients

P. Menheere, J. Sels, A. Kruseman, 1992, Diabetes Care.

Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

F. Vleggaar, R. Weersma, C. Ponsioen, 2013, Hepatology.

Actinomycosis of the abdominal wall after cholecystectomy: transferral theory.

P. D. de Vries, Evert-jan Kooi, P. Kingma, 2016, The Netherlands journal of medicine.

Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands

C. Ponsioen, G. D'Haens, K. Boonstra, 2016, European journal of gastroenterology & hepatology.

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.

P. Bossuyt, E. Consten, C. Buskens, 2017, The lancet. Gastroenterology & hepatology.

Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

F. Vleggaar, R. Weersma, C. Ponsioen, 2013, Hepatology.

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.

P. Bossuyt, W. Bemelman, R. van Hillegersberg, 2017, The lancet. Gastroenterology & hepatology.

alpha-Glucosidase inhibition by miglitol in NIDDM patients.

P. Menheere, J. Sels, P. Kingma, 1992, Diabetes Care.

Su1313 Epidemiology and Characteristics of Inflammatory Bowel Disease in a Large Population-Based Cohort in the Netherlands

C. Ponsioen, G. D'Haens, K. Boonstra, 2015 .